A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- NA · SINGLE GROUP · HEALTH SERVICES RESEARCH · NONE
- Evidence population
- Human clinical study registration
- Participants
- 40
- Population
- ALL · 50 Years to 80 Years
- Duration
- 2025-09-22 to 2026-05-08
- Intervention
- Supervised exercise program; a balanced micronutrient blend
- Comparator
- Not reported
- Outcomes measured
- Change in muscle mass measured via B- mode ultrasound — Baseline and 12 weeks; Change on Fecal Bifidobacterium level measured via stool microbiome analysis — Baseline, 6 weeks and 12 weeks; Change in cognitive performance National Institutes of Health Toolbox Cognition Battery - Fluid composite — Baseline an…; Change in the immune function (CD4+: CD8+ ratio) — Baseline, 6 weeks and 12 weeks; Change in cardiorespiratory fitness (Peak VO₂) — Baseline and 12 weeks; Change in Muscle Strength assessed using 1RM strength test — Baseline and 12 weeks; Change in Handgrip Strength Measured by Dynamometer — Baseline, 6 weeks and 12 weeks; Stool consistency, frequency and gastrointestinal tolerance — baseline, 12 weeks; Change in Biological age determined by DNAm clocks — baseline, 12 weeks; Change in advanced glycation end-products (AGEs) assessed using skin autofluorescence. — Baseline, 12 weeks; Change in inflammatory markers (IL-6, IL-10, TNF-α and IFN-γ) — Baseline, 6 weeks and 12 weeks; Change in immune function as measured by Lymphocyte/neutrophil ratio — Baseline, 6 weeks and 12 weeks; Change in blood pressure measured using SphygmoCor-XCEL — baseline, 6 weeks, 12 weeks; Change in Arterial stiffness measured via SphygmoCor-XCEL — Baseline and 12 weeks; Change in Physical Activity Levels Measured by Wearable Devices — baseline, 12 weeks; Change in heart rate measured with SphygmoCor-XCEL — Baseline, 6 weeks and 12 weeks; Change in Lean Mass measured by Dual-Energy X-ray Absorptiometry (DXA) — Baseline and 12 weeks; Change in Body Composition Measured by Bioimpedance (InBody 770) — Baseline and 12 weeks; Change in Quality of life assessed by The 36-Item Short Form Health Survey questionnaire (SF-36) — baseline, 12 weeks; Change in Quality of Life Measured by EuroQol 5-Dimensions (EQ-5D) — Baseline, 12 weeks
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Exercise · 100%Title contains controlled term: exercise. Abstract contains controlled term: exercise. Source terminology contains: exercise. Title supplies longevity context: longevity, frail. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.